Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Wells Fargo Reiterates Overweight Rating on Johnson & Johnson (JNJ)
November 19, 2020 6:46 AM ESTWells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $172.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's virtual booth tour, ahead of its analyst day.
On its Q3 call, JNJ indicated that it expected Q4 MD recovery to continue with... More
Pfizer (PFE), BioNTech (BNTX) Confirm Phase 3 Study of COVID-19 Vaccine Candidate Shows 95% Efficacy
November 18, 2020 7:00 AM ESTPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the studys primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p... More
